American Journal of Epidemiology is a premier peer-reviewed journal published by Oxford University Press, focusing on the advancement of epidemiological knowledge and methodology since its inception in 1921. With an ISSN of 0002-9262 and E-ISSN 1476-6256, this influential journal serves as a vital resource for researchers and practitioners worldwide, highlighting significant epidemiological findings and fostering dialogue within the field. Ranked in the Q2 category of Epidemiology and holding a commendable 80th percentile in Scopus' ranking, the journal continues to play a significant role in shaping public health policies and practices. Although the journal is not open access, it remains accessible through institutional subscriptions, ensuring comprehensive discourse on pressing epidemiological issues. By continuously publishing high-quality research that informs disease prevention and control strategies, the American Journal of Epidemiology stands at the forefront of epidemiological inquiry, promoting improved health outcomes on a global scale.

Obesity Science & Practice is a prestigious, peer-reviewed journal dedicated to advancing knowledge and research in the fields of obesity, endocrinology, diabetes, metabolism, and nutrition. Published by Wiley, this journal has established itself as a vital resource for researchers, healthcare professionals, and students interested in the latest evidence-based practices and innovations in obesity management. With an impact factor that reflects its significance, and ranked in the Q2 category for both Endocrinology, Diabetes and Metabolism, and Nutrition and Dietetics in 2023, the journal aims to foster interdisciplinary collaboration and dissemination of cutting-edge research. Since its transition to Open Access in 2015, Obesity Science & Practice has become increasingly accessible, emphasizing the importance of making research findings available to a wider audience. This convergence of expertise and commitment to public health makes the journal an essential forum for advancing scholarship and practice in tackling widespread global health challenges.

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, published by Lippincott Williams & Wilkins, stands as a premier resource in the fields of orthopedics, sports medicine, and surgery. With an impressive impact factor and a notable ranking in the Q1 quartile across multiple categories, this journal is essential for researchers and practitioners seeking the latest advancements and evidence-based practices. Since its inception in 1946, the journal has provided a platform for the dissemination of cutting-edge research, reviews, and innovative surgical techniques, significantly contributing to the improvement of patient outcomes in musculoskeletal health. The Scopus rankings reinforce its stature, placing it among the top 14 and 13 journals in surgery and orthopedics, respectively. While not an open-access journal, it offers wide-ranging access options tailored to both academic and clinical users. For professionals dedicated to advancing orthopedic and surgical knowledge, the JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME is an invaluable asset that invigorates ongoing learning and fosters collaboration within the medical community.

Open Medicine, with ISSN 2391-5463 and E-ISSN 2391-5463, is a distinguished peer-reviewed journal published by De Gruyter Poland Sp. z o.o, focusing on a broad array of topics in the field of medicine. Since its inception in 2013, the journal has maintained an Open Access policy, fostering the dissemination of scientific knowledge across global audiences and promoting collaborative research efforts. Based in Germany, Open Medicine has established itself within the medical community, achieving a respectable Q3 ranking in the category of Medicine (Miscellaneous) as of 2023, and placing in the 72nd percentile in general medicine according to Scopus rankings. The journal aims to bridge gaps in research by offering a platform for innovative studies, clinical trials, and comprehensive reviews that advance medical knowledge and practice. With a commitment to enhancing accessibility and visibility of research, Open Medicine plays a vital role in encouraging the continued development of the medical field, making it an essential resource for researchers, professionals, and students alike.

Welcome to the Journal of Evidence Based Medicine, a premier platform dedicated to advancing the field of health policy and medicine through rigorous research and scholarship. Published by WILEY, this esteemed journal, with an ISSN of 1756-5383 and E-ISSN 1756-5391, is headquartered in the United Kingdom and serves as a pivotal resource for disseminating high-quality evidence-based research. Operating within the converged years from 2008 to 2024, the journal boasts a remarkable standing, achieving a Q1 category ranking in both Health Policy and Medicine (Miscellaneous) for 2023, and ranking #12 out of 310 in the Scopus Ranks for Medicine & Health Policy, placing it in the 96th percentile. This commitment to excellence makes the journal a significant conduit for professionals, researchers, and students who seek to inform their practices with the latest evidence and foster advancements in health policy and medical practice. While currently not open access, the journal maintains a rigorous selection process to ensure the highest standards of publication, appealing to anyone intent on exploring groundbreaking studies that shape the health landscape globally.

Systematic Reviews is a leading open-access journal published by BMC, focused on the comprehensive and systematic analysis of health-related literature. Established in 2002, the journal has significantly contributed to the field of Medicine (miscellaneous) and has been recognized as a Q1 journal in the 2023 category quartiles, ranking 48 out of 398 in its field with an impressive 88th percentile on Scopus. With its open-access model initiated in 2012, Systematic Reviews ensures that vital research findings are freely available to researchers, practitioners, and students worldwide. The journal aims to publish high-quality systematic reviews that inform clinical guidelines, healthcare decisions, and policy-making, contributing to evidence-based practice in medicine. Located in the United Kingdom, it serves as an essential resource for advancing knowledge within the global health community, encouraging rigorous research methodology and facilitating the dissemination of impactful findings.

Pediatric Reports is a distinguished open-access journal dedicated to the field of pediatrics, published by MDPI from its headquarters in Basel, Switzerland. Since its inception in 2009, the journal has aimed to advance the understanding and treatment of pediatric health through the publication of high-quality research articles, reviews, and clinical studies. With its current ranking in the Q2 category for Pediatrics, Pediatric Reports stands out in its commitment to disseminating innovative findings that contribute to the well-being of children. The journal is indexed in key databases and has gained recognition within the scientific community, as evidenced by its respectable Scopus rankings in Nursing and Pediatrics. Researchers, healthcare professionals, and students will find this journal to be an invaluable resource, as it fosters collaborative knowledge exchange and promotes evidence-based practices in pediatric care.

ClinicoEconomics and Outcomes Research is a prestigious open-access journal published by DOVE MEDICAL PRESS LTD, located in New Zealand. Since its inception in 2009, it has established itself as a vital resource for researchers and practitioners in the fields of economics, health policy, and outcomes research. With a commendable impact reflected in its rankings—Q1 in Economics, Econometrics and Finance and Q2 in Health Policy—the journal effectively bridges the gap between economic evaluation and healthcare delivery. This publication is particularly significant for those focused on the economic implications of health interventions, policy analysis, and decision-making processes in healthcare systems. As an open-access journal, ClinicoEconomics and Outcomes Research ensures that its valuable content is widely accessible, enhancing knowledge dissemination and fostering collaboration among academia, industry, and policymakers. With an ambition to contribute to the improvement of health outcomes through rigorous research, it invites submissions that address the multifaceted challenges facing the economics of healthcare today. Join the scholarly dialogue where innovative ideas in health economics thrive!

The International Journal of Noncommunicable Diseases, published by Wolters Kluwer Medknow Publications, is a leading open-access journal dedicated to advancing research in the field of noncommunicable diseases (NCDs). Since its inception in 2016, the journal has provided a robust platform for the dissemination of high-quality studies, reviews, and case reports that address the growing burden of NCDs globally. With a commitment to enhancing knowledge and understanding, the journal aims to navigate the complexities of prevention, diagnosis, management, and policy implications related to diseases such as diabetes, cardiovascular conditions, and cancers. The journal features an inclusive editorial board made up of renowned experts in the field, ensuring rigorous peer review and maintaining a high standard of scholarly excellence. As an open-access journal, it promotes widespread availability of its content, fostering collaboration and innovation among researchers, healthcare professionals, and students alike. Engage with the latest research and contribute to the growing body of knowledge in this critical area of public health by exploring the International Journal of Noncommunicable Diseases.

Contemporary Clinical Trials Communications, published by ELSEVIER INC, serves as a pivotal resource in the evolving fields of medicine and pharmacology, especially with its commitment to open access since 2015. With the E-ISSN 2451-8654, this journal is dedicated to disseminating high-quality research that examines contemporary clinical trial methodologies and their applications in improving healthcare outcomes. Situated in the United States, its impressive ranking, with a Q2 status in both Medicine (miscellaneous) and Pharmacology for 2023, highlights its significance and impact within the scientific community. Ranking #199 out of 636 in General Medicine and #217 out of 313 in Pharmacology on the Scopus scale, the journal aims to foster innovative discussions and developments among researchers, professionals, and students, making it an essential tool for those seeking to stay at the forefront of clinical research and trials.